The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -58.61%.However, over the last six months, we can see a stronger performance of -65.51%. Over the last 30 days, the price of CCCC has fallen by 7.97%. And in the last five days, it has fallen by -5.10%.
C4 Therapeutics Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $7.66 on 07/16/24 and the lowest value was $1.09 on 04/17/25.
52-week price history of CCCC Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. C4 Therapeutics Inc’s current trading price is -80.55% away from its 52-week high, while its distance from the 52-week low is 37.33%. The stock’s price range during this period has varied between$1.09 and $7.66. The C4 Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.96 million for the day, a figure considerably lower than their average daily volume of 1.09 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
C4 Therapeutics Inc (CCCC) has experienced a quarterly decline of -28.37% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 105.80M and boasts a workforce of 110 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
CCCC’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CCCC stands at 0.33. Similarly, the long-term debt-to-equity ratio is also 0.30.
